Provided by Tiger Trade Technology Pte. Ltd.

PAVmed

2.70
-0.9900-26.83%
Post-market: 2.900.2000+7.41%17:47 EDT
Volume:187.71K
Turnover:564.35K
Market Cap:21.59M
PE:-0.16
High:3.69
Open:3.61
Low:2.61
Close:3.69
52wk High:28.44
52wk Low:2.61
Shares:8.00M
Float Shares:3.83M
Volume Ratio:18.38
T/O Rate:4.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.4698
EPS(LYR):-5.6300
ROE:-64.78%
ROA:-39.69%
PB:0.69
PE(LYR):-0.48

Loading ...

PAVmed Launches New At-the-Market Equity Offering

TIPRANKS
·
Sep 10

PAVmed Enters At-the-Market Equity Sales Agreement for up to USD 9.4 Million of Stock

Reuters
·
Sep 10

PAVmed Maintained at Buy as Analyst Sees Long-Term Growth Upside; $16 Price Target Reaffirmed

TIPRANKS
·
Aug 16

PAVmed Reports Q2 2026 Results and Operational Progress

TIPRANKS
·
Aug 14

PAVmed Q2 FY26 GAAP Net Loss Narrows to $5.48 Million; Revenue Rises to $33,000

Reuters
·
Aug 14

PAVmed Q2 Adj. EPS $(0.27) Beats $(0.58) Estimate, Sales $33.000K Miss $72.000K Estimate

Benzinga Earnings
·
Aug 14

Press Release: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 14

PAVmed Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

PAVmed Subsidiary Lucid Diagnostics Posts 2Q Revenue of USD 1.5 Million

Reuters
·
Aug 13

Press Release: Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 13

Lucid Diagnostics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Lucid Diagnostics Q2 FY26 Revenue Rises 25% to USD 1.5 Million

Reuters
·
Aug 13

PAVmed Inc Expected to Post a Loss of 47 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Lucid Diagnostics Inc Expected to Post a Loss of 7 Cents a Share - Earnings Preview

Reuters
·
Aug 11

PAVmed Unit Lucid Diagnostics Wins Concert Commercial Coverage Policy for EsoGuard Test

Reuters
·
Aug 05

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for Its Esoguard® Esophageal DNA Test

THOMSON REUTERS
·
Aug 05

Lucid Diagnostics to Present at Needham, Canaccord Investor Conferences

Reuters
·
Aug 04

Lucid Diagnostics Management Participates in Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Aug 04

PAVmed to Host Business Update Call, Report Q2 2026 Results

Reuters
·
Jul 31

Lucid Diagnostics Schedules Business Update Call to Discuss Q2 2026 Results

Reuters
·
Jul 30